JP2023550628A5 - - Google Patents

Info

Publication number
JP2023550628A5
JP2023550628A5 JP2023530833A JP2023530833A JP2023550628A5 JP 2023550628 A5 JP2023550628 A5 JP 2023550628A5 JP 2023530833 A JP2023530833 A JP 2023530833A JP 2023530833 A JP2023530833 A JP 2023530833A JP 2023550628 A5 JP2023550628 A5 JP 2023550628A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
antigen
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023530833A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023550628A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/060369 external-priority patent/WO2022109403A1/en
Publication of JP2023550628A publication Critical patent/JP2023550628A/ja
Publication of JP2023550628A5 publication Critical patent/JP2023550628A5/ja
Pending legal-status Critical Current

Links

JP2023530833A 2020-11-23 2021-11-22 抗原結合分子およびその使用 Pending JP2023550628A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063117383P 2020-11-23 2020-11-23
US63/117,383 2020-11-23
PCT/US2021/060369 WO2022109403A1 (en) 2020-11-23 2021-11-22 Antigen-binding molecules and uses thereof

Publications (2)

Publication Number Publication Date
JP2023550628A JP2023550628A (ja) 2023-12-04
JP2023550628A5 true JP2023550628A5 (https=) 2024-11-28

Family

ID=81709767

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023530833A Pending JP2023550628A (ja) 2020-11-23 2021-11-22 抗原結合分子およびその使用

Country Status (8)

Country Link
US (1) US20230416356A1 (https=)
EP (1) EP4247848A4 (https=)
JP (1) JP2023550628A (https=)
KR (1) KR20230118864A (https=)
CN (1) CN116981691A (https=)
AU (1) AU2021383841A1 (https=)
CA (1) CA3199586A1 (https=)
WO (1) WO2022109403A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4602073A2 (en) * 2022-11-15 2025-08-20 Purdue Research Foundation Canine pd-l1 antibody, antigen binding fragments thereof, and methods of use thereof
GB202405576D0 (en) * 2024-04-19 2024-06-05 272Bio Ltd VHH antibodies
CN121362250A (zh) * 2024-07-19 2026-01-20 普米斯生物技术(珠海)有限公司 抗il-31抗体、其药物组合物及用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME03057B (me) * 2007-12-07 2019-01-20 Zymogenetics Inc Molekuli humanizovanih antitela specifični za il-31
WO2009138494A2 (en) * 2008-05-15 2009-11-19 Ablynx N.V. Amino acid sequences directed against toll-like receptors and polypeptides comprising the same for the treatment of diseases related to toll-like receptors
US8790651B2 (en) * 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
JP2016522168A (ja) * 2013-04-05 2016-07-28 ジェネンテック, インコーポレイテッド 抗il−4抗体及び二重特異性抗体及びその使用
MA40824A (fr) * 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
JP6800853B2 (ja) * 2014-12-11 2020-12-16 ピエール、ファーブル、メディカマン 抗c10orf54抗体およびその使用
GB201621439D0 (en) * 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
US10093731B2 (en) * 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use
GB201710835D0 (en) * 2017-07-05 2017-08-16 Ucl Business Plc ROR1 Antibodies
MX2020006105A (es) * 2017-12-11 2020-11-09 Ubi Ip Holdings Inmunógenos peptídicos de il-31 y formulaciones de estos para el tratamiento y/o la prevención de la dermatitis atópica.
CA3093539A1 (en) * 2018-03-16 2019-09-19 Zoetis Services Llc Interleukin-31 monoclonal antibodies for veterinary use
US11433139B2 (en) * 2018-03-16 2022-09-06 Zoetis Services Llc Peptide vaccines against interleukin-31
WO2019183449A1 (en) * 2018-03-23 2019-09-26 North Carolina State University Methods and compositions for allergic disorders
US20190300610A1 (en) * 2018-03-29 2019-10-03 Hummingbird Bioscience Pte. Ltd. Vista antigen-binding molecules

Similar Documents

Publication Publication Date Title
US6881557B2 (en) Super humanized antibodies
EP3689909A1 (en) Tigit antibody, antigen-binding fragment thereof, and medical use thereof
JP5738294B2 (ja) 抗vegfモノクローナル抗体およびその抗体を含む薬学的組成物
CN110669135B (zh) 一种双特异性抗体及其用途
US20050288491A1 (en) Super-humanized antibodies against respiratory syncytial virus
JP2020536532A5 (https=)
JP2023550628A5 (https=)
RU2004121673A (ru) Человеческие полипептиды, вызывающие или опосредующие лизис клеток, включая клетки лимфоидных опухолей
JP2005537009A (ja) 免疫系分子をヒト化する方法
JP7821159B2 (ja) Bcmaと結合する単一可変ドメイン及び抗原結合分子
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
JP2021530244A5 (https=)
JP2018522888A5 (https=)
JP2020007318A5 (https=)
CN111808193B (zh) 可结合人cd38的纳米抗体及其应用
JP2005528914A5 (https=)
JP2022512646A5 (https=)
CN110461874B (zh) 抗gitr抗体、其抗原结合片段及其医药用途
WO2022228183A1 (zh) 抗siglec15抗体及其制备方法和用途
US9273138B2 (en) Humanized forms of monoclonal antibodies to human GnRH receptor
Ren et al. The role of the light chain in the structure and binding activity of two cattle antibodies that neutralize bovine respiratory syncytial virus
JP2019514343A5 (https=)
KR940006602A (ko) 면역글로불린 이소타입에 대한 재조형 모노클로날 항체
CN110913894A (zh) 抗csf-1r抗体、其抗原结合片段及其医药用途
US20240059764A1 (en) ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF